Cipla (CPLFY) Insider Ownership : 0.00 % (As of May. 10, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Cipla Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cipla's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cipla's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cipla's Float Percentage Of Total Shares Outstanding is 0.00%.

Cipla Insider Ownership Historical Data

The historical data trend for Cipla's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Insider Ownership Chart

Cipla Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Insider Ownership

Get a 7-Day Free Trial

Cipla Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Insider Ownership	Get a 7-Day Free Trial															-	-	-	-	-

Cipla Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Cipla (CPLFY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (OTCPK:CPLFY) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

CIPLA:India 500087:India

Address

Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.cipla.com

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large global presence. Cipla's growth strategy focuses on new product launches. It has two segments Pharmaceuticals and new ventures.